MoneyWorks4Me

Bacil Pharma - Quaterly Results

14 Aug 2023 Evaluate
A slight decline in the revenue of Rs. 0.00 millions was seen for the June 2023 quarter as against Rs. 0.00 millions during year-ago period.A slender decline of -19.05% was recorded to Rs. 0.17  millions from Rs. 0.21 millions in the corresponding previous quarter.The company reported a degrowth in operating Profit to 0.18 millions from 0.22 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.48 0.65 -26.15 0.48 0.65 -26.15 1.15 0.58 98.28
PBIDT 0.18 0.22 -18.18 0.18 0.22 -18.18 -0.99 -38.56 -97.43
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 0.18 0.22 -18.18 0.18 0.22 -18.18 -0.99 -38.56 -97.43
Depreciation 0.01 0.01 0.00 0.01 0.01 0.00 0.03 0.04 -25.00
PBT 0.17 0.21 -19.05 0.17 0.21 -19.05 -1.02 -38.60 -97.36
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.17 0.21 -19.05 0.17 0.21 -19.05 -1.02 -38.60 -97.36
Equity 58.90 58.90 0.00 58.90 58.90 0.00 58.90 58.90 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..